Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,698,558

« Back to Dashboard

Summary for Patent: 5,698,558

Title: Methods for treating allergic disorders using optically pure (-) cetirizine
Abstract:Methods are disclosed utilizing optically pure (-) cetirizine for the treatment of seasonal and perennial allergic rhinitis in humans while avoiding the concomitant liability of adverse effects associated with the racemic mixture of cetirizine. The optically pure (-) isomer is also useful for the treatment of allergic asthma.
Inventor(s): Gray; Nancy M. (Marlboro, MA)
Assignee: Sepracor, Inc. (Marlborough, MA)
Application Number:08/789,502
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ucb Inc
XYZAL
levocetirizine dihydrochloride
SOLUTION;ORAL022157Jan 28, 2008RXYes5,698,558*PED<disabled>Y
Ucb Inc
XYZAL
levocetirizine dihydrochloride
TABLET;ORAL022064May 25, 2007RXYes5,698,558*PED<disabled>Y
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,698,558

Country Document Number Publication Date
WIPO (PCT)9406429Mar 31, 1994
Netherlands300085May 01, 2002
Luxembourg90898Apr 08, 2002
Japan2006036791Feb 09, 2006
JapanH08501561Feb 20, 1996
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc